Skeletal Muscle Relaxants: Adverse Effects
Parkinson's Disease: Treatment
Drugs for Treatment of Constipation-Predominant IBS
Restless Leg Syndrome and Night Terrors
Drugs for Treatment of Diarrhea-Predominant IBS
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 27, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Prashant Tibrewal1, Rachel Cheng2,3, Tarun Bastiampillai4
1Cramond Clinic, The Queen Elizabeth Hospital, Woodville, SA, Australia.
No abstract available in PubMed .
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020